F-spondin deficient mice have a high bone mass phenotype

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Palmer, Glyn D ^a,c   Attur, Mukundan G ^a   Yang, Qing ^a   Liu, James ^a   Moon, Paxton ^b   Beier, Frank ^b   Abramson, Steven B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WESTERN UNIVERSITY   (Canada)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; F SPONDIN; SCLEROPROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; F-SPONDIN PROTEIN, MOUSE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE DEVELOPMENT; BONE MASS; BONE TURNOVER; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMUR; GENOTYPE; GROWTH PLATE; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SPON1 GENE; TIBIA; ANATOMY AND HISTOLOGY; ANIMAL; BLOOD; BONE; CYTOLOGY; DEFICIENCY; GENE ORDER; GENE TARGETING; KNOCKOUT MOUSE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PHOSPHORYLATION; RADIOGRAPHY;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; CHONDROCYTES; EXTRACELLULAR MATRIX PROTEINS; GENE ORDER; GENE TARGETING; GENOTYPE; MICE; MICE, KNOCKOUT; OSTEOCLASTS; PHENOTYPE; PHOSPHORYLATION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; X-RAY MICROTOMOGRAPHY;

EID: 84902211442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098388     Document Type: Article

References (34)

1. Klar A, Baldassare M, Jessell TM (1992) F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cell 69(1):95-110.
2. Burstyn-Cohen T, Tzarfaty V, Frumkin A, Feinstein Y, Stoeckli E, et al. (1999) F-Spondin is required for accurate pathfinding of commissural axons at the floor plate. Neuron 23(2):233-46. (Pubitemid 29315720)
3. Feinstein Y, Borrell V, Garcia C, Burstyn-Cohen T, Tzarfaty V, et al. (1999) F-spondin and mindin: two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons. Development 126(16):3637-48. (Pubitemid 29419519)
4. Tzarfati-Majar V, Burstyn-Cohen T, Klar A (2001) F-spondin is a contact-repellent molecule for embryonic motor neurons. Proc Natl Acad Sci U S A 98(8):4722-7. (Pubitemid 32295043)
5. Miyamoto K, Morishita Y, Yamazaki M, Minamino N, Kangawa K, et al. (2001) Isolation and characterization of vascular smooth muscle cell growth promoting factor from bovine ovarian follicular fluid and its cDNA cloning from bovine and human ovary. Arch Biochem Biophys 390(1):93-100. (Pubitemid 32493574)
6. Kitagawa M, Ao M, Miyauchi M, Abiko Y, Takata T (2012) F-spondin regulates the differentiation of human cementoblast-like (HCEM) cells via BMP7 expression. Biochem Biophys Res Commun 418(2):229-33.
7. Palmer GD, Piton AH, Thant LM, Oliveira SM, D'Angelo M, et al. (2010) F-spondin regulates chondrocyte terminal differentiation and endochondral bone formation. J Orthop Res 28(10):1323-9.
8. Attur MG, Palmer GD, Al-Mussawir HE, Dave M, Teixeira CC, et al. (2009) F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation. Faseb J 23(1):79-89.
9. Hoe HS, Wessner D, Beffert U, Becker AG, Matsuoka Y, et al. (2005) F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein. Mol Cell Biol 25(21):9259-68. (Pubitemid 41507828)
10. Peterziel H, Sackmann T, Strelau J, Kuhn PH, Lichtenthaler SF, et al. (2011) F-spondin regulates neuronal survival through activation of disabled-1 in the chicken ciliary ganglion. Mol Cell Neurosci 46(2):483-97.
11. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factorbeta. J Biol Chem 274(19):13586-93.
12. Kitagawa M, Kudo Y, Iizuka S, Ogawa I, Abiko Y, et al. (2006) Effect of F-spondin on cementoblastic differentiation of human periodontal ligament cells. Biochem Biophys Res Commun 349(3):1050-6. (Pubitemid 44380203)
13. Oka H, Mori M, Kihara H (2011) F-spondin inhibits migration and differentiation of osteoclastic precursors. J Periodontol 82(12):1776-83.
14. Appleton CT, Pitelka V, Henry J, Beier F (2007) Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 56(6):1854-68. (Pubitemid 47110385)
15. Wang G, Woods A, Agoston H, Ulici V, Glogauer M, et al. (2007) Genetic ablation of Rac1 in cartilage results in chondrodysplasia. Dev Biol 306(2):612-23. (Pubitemid 46873537)
16. Ulici V, Hoenselaar KD, Agoston H, McErlain DD, Umoh J, et al. (2009) The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone 45(6):1133-45.
17. Liu CC, Sherrard DJ, Maloney NA, Howard GA (1987) Reactivation of inhibited bone acid phosphatase and its significance in bone histomorphometry. J Histochem Cytochem 35(12):1355-63. (Pubitemid 17165240)
18. Barka T, Anderson PJ (1962) Histochemical Methods for Acid Phosphatase using Hexazonium Pararosanilin as couplet. J. Histochem. Cytochem 10:741-47.
19. Gosset M, Berenbaum F, Thirion S, Jacques C (2008) Primary culture and phenotyping of murine chondrocytes. Nat Protoc 3(8):1253-60.
20. Janssens K, ten Dijke P, Janssens S, Van Hul W (2005) Transforming growth factor-beta1 to the bone. Endocr Rev 26(6):743-74.
21. Zuscik MJ, Baden JF, Wu Q, Sheu TJ, Schwarz EM, et al. (2004) 5-azacytidine alters TGF-beta and BMP signaling and induces maturation in articular chondrocytes. J Cell Biochem 92(2):316-31.
22. Ferguson CM, Schwarz EM, Reynolds PR, Puzas JE, Rosier RN, et al. (2000) Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation. Endocrinology 141(12):4728-35. (Pubitemid 32055153)
23. Kawamura I, Maeda S, Imamura K, Setoguchi T, Yokouchi M, et al. (2012) SnoN suppresses maturation of chondrocytes by mediating signal cross-talk between transforming growth factor-beta and bone morphogenetic protein pathways. J Biol Chem 287(34):29101-13.
24. Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6):685-700. (Pubitemid 36724933)
25. van der Kraan PM, Blaney Davidson EN, Blom A, van den Berg WB (2009) TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage 17(12) :1539-45.
26. Delany AM, Hankenson KD (2009) Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling. J Cell Commun Signal 3(3-4):227-38.
27. Hankenson KD, Hormuzdi SG, Meganck JA, Bornstein P (2005) Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femursl head. Mol Cell Biol 25(13):5599-606. (Pubitemid 40853594)
28. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML (2007) Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 22(8):1197-207. (Pubitemid 351339702)
29. Xiao Y, Fu H, Prasadam I, Yang YC, Hollinger JO (2007) Gene expression profiling of bone marrow stromal cells from juvenile, adult, aged and osteoporotic rats: with an emphasis on osteoporosis. Bone 40(3):700-15. (Pubitemid 46187234)
30. Dabovic B, Levasseur R, Zambuto L, Chen Y, Karsenty G, et al. (2005) Osteopetrosis-like phenotype in latent TGF-beta binding protein 3 deficient mice. Bone 37(1):25-31. (Pubitemid 40848414)
31. Nistala H, Lee-Arteaga S, Smaldone S, Siciliano G, Carta L, et al. (2010) Fibrillin-1 and -2 differentially modulate endogenous TGF-beta and BMP bioavailability during bone formation. J Cell Biol 190(6):1107-21.
32. Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, et al. (2008) Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283(13):8412-22.
33. Ehnert S, Zhao J, Pscherer S, Freude T, Dooley S, et al. (2012) Transforming growth factor beta1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? BMC Med 10:101.
34. Matsumoto Y, Otsuka F, Hino J, Miyoshi T, Takano M, et al. (2012) Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling. Mol Cell Endocrinol 350(1):78-86.